Nebulized Heparin for Prevention of Acute Lung Injury in Smoke Inhalation Injury
Status:
Recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
This study aims to examine the value of nebulized heparin for prevention of acute lung injury
in adult patients suffering smoke inhalation injury.
Patients will be randomized to receive nebulized heparin or an equal volume of normal saline
for 14 days and the incidence of acute lung injury will be compared in either group.